Studies on human gastrointestinal bacterial azoreductase, the enzyme activates azo pro-drugs in the treatment of inflammatory bowel disease (IBD)

Chan-Ju Wang, Chris Hagemeier, Nawreen Rahman, Lori Hu, Michael Coughtrie, George Macfarlane, Ed Lowe, Edith Sim, Isaac Westwood

    Research output: Contribution to journalBook/Film/Article review

    Original languageEnglish
    Pages (from-to)132-133
    Number of pages2
    JournalDrug Metabolism Reviews
    Volume40
    Issue numbers1
    DOIs
    Publication statusPublished - 2008

    Cite this

    Wang, C-J., Hagemeier, C., Rahman, N., Hu, L., Coughtrie, M., Macfarlane, G., Lowe, E., Sim, E., & Westwood, I. (2008). Studies on human gastrointestinal bacterial azoreductase, the enzyme activates azo pro-drugs in the treatment of inflammatory bowel disease (IBD). Drug Metabolism Reviews, 40(s1), 132-133. https://doi.org/10.1080/03602530801949332